| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |